ReviewFrontiers in pharmacology2026
From chemical composition to clinical application: the value of bile-based traditional Chinese medicines in the treatment of liver diseases.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bile-based traditional Chinese medicines comprise a special category of medicinal materials that have distinct value in the treatment of liver diseases. Bile acids are the primary active components of bile-based TCMs. These components exert significant therapeutic effects by targeting key signaling pathways related to disease progression through bile acid receptors such as FXR and TGR5. Herein, we comprehensively review the chemical composition, pharmacological effects, and clinical applications of bile-based TCMs with a particular focus on their potential and recent research progress in the treatment of liver diseases. The bile acid components of bile-based TCMs have dual "Yin and Yang" effects in the treatment of liver diseases. They show therapeutic actions such as anti-inflammation, hepatoprotection and anti-fibrosis, and they may also promote disease through certain constituents like TCA and GCA. This dual nature creates a complex balance between benefit and risk. It highlights the mechanistic complexity of bile-based TCMs in treating liver diseases and presents new challenges for their precise clinical application. Future research needs to thoroughly analyze the composition and efficacy of bile-based TCMs, clarify their mechanisms of action and pharmacological effects, and explore component modification and combination therapies. This will provide a scientific basis and innovative ideas for precise application of bile-based TCMs and development of new, more effective and safer treatment options for patients with liver diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.